ClinicalTrials.gov
ClinicalTrials.gov Menu

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01182350
Recruitment Status : Active, not recruiting
First Posted : August 16, 2010
Last Update Posted : April 4, 2018
Sponsor:
Collaborators:
Boston Children’s Hospital
University of California, San Francisco
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Healthcare of Atlanta
Children's Hospital Colorado
Children's Hospital Los Angeles
Children's Hospital of Michigan
Children's Hospitals and Clinics of Minnesota
Cook Children's Medical Center
OHSU Doernbecher Children's Hospital
Duke University
Johns Hopkins University
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Nemours Children's Clinic
New York University
Milton S. Hershey Medical Center
Seattle Children's Hospital
Lucile Packard Children's Hospital
University of Louisville
Children's Research Institute
Washington University School of Medicine
Phoenix Children's Hospital
Medical University of South Carolina
Information provided by (Responsible Party):
Mark W. Kieran, MD, PhD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 2018
  Study Completion Date : No date given